8-K: Regenerex Pharma Changes Auditor Amid Going Concern Concerns

Regenerex Pharma, Inc. announced the resignation of its independent auditor, dbbmckennon, effective August 31, 2026, citing internal decisions, with the company seeking a successor.

Summary

• Regenerex Pharma, Inc. (the Company) has accepted the resignation of its independent registered public accounting firm, dbbmckennon, effective August 31, 2026.
• dbbmckennon had served as the Company's auditor since 2017.
• The auditor's reports for the fiscal years ended December 31, 2025, and March 31, 2025, included an explanatory paragraph regarding substantial doubt about the Company's ability to continue as a going concern.
• The report for the transition period ending December 31, 2025, also noted a revision to financial statements to disclose related party transactions.
• There were no disagreements or reportable events with dbbmckennon during the Company's two most recent fiscal years.
• The Company is actively seeking a successor independent registered public accounting firm and aims to complete its outstanding periodic reports.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative development due to the unexpected resignation of the auditor, which raises concerns about the company's financial reporting and going concern status.

Positives

• The company is actively seeking a successor auditor to ensure continued financial reporting.
• The company states there were no disagreements with the outgoing auditor on accounting principles or practices.
• The company is committed to completing its outstanding periodic reports and bringing filings current.

Negatives

• The independent auditor, dbbmckennon, resigned due to an internal decision to cease providing services.
• Previous audit reports highlighted substantial doubt about the Company's ability to continue as a going concern.
• Financial statements required revisions to disclose related party transactions.
• The company is currently without an independent registered public accounting firm.

Risks

• Substantial doubt about the Company's ability to continue as a going concern, as noted in previous audit reports.
• Potential difficulties in engaging a new auditor promptly, which could further delay financial reporting.
• Increased scrutiny from regulators and investors due to the auditor change and going concern issues.
• The need to disclose related party transactions may indicate potential conflicts of interest or financial irregularities.

Future Outlook

The company is focused on engaging a successor independent registered public accounting firm and completing its outstanding periodic reports to bring its filings current.

Management Comments

• The Company's Board of Directors has acknowledged and accepted dbbmckennon's decision to cease providing services.
• The Company intends to complete the engagement process as promptly as practicable and will cooperate with both dbbmckennon and the successor independent registered public accounting firm to facilitate an orderly transition.
• The Company intends to work closely with its successor independent registered public accounting firm to complete the Company's outstanding financial reporting obligations.

Industry Context

StockSavvy.ai notes that auditor changes, especially when coupled with going concern warnings, are often viewed negatively by the market. This situation can signal underlying financial distress or reporting challenges that require close investor attention.

Related Party Transactions

• The financial statements for the transition period ending December 31, 2025, required revision to disclose certain related party transactions.

Stakeholder Impact

• Shareholders may face increased uncertainty and potential stock price volatility due to auditor resignation and going concern issues.
• Creditors may become more cautious due to concerns about the company's ability to continue as a going concern.
• Potential investors may be deterred by the lack of current financial reporting and the auditor's concerns.

Next Steps

• Engage a successor independent registered public accounting firm.
• Complete outstanding periodic reports.
• Bring company filings current.

Key Dates

Recommendation

The resignation of the auditor, coupled with prior going concern warnings and the need to disclose related party transactions, presents significant financial and operational risks. This situation warrants a cautious approach, suggesting a sell recommendation until clarity is achieved regarding the company's financial stability and reporting integrity.

Keywords

Auditor Resignation, Going Concern, Financial Reporting, Related Party Transactions, Form 8-K, Accounting Firm Change, Nevada, Regenerex Pharma